Examining unit costs for COVID-19 case management in Kenya

Abstract

IntroductionWe estimated unit costs for COVID-19 case management for patients with asymptomatic, mild-to-moderate, severe and critical COVID-19 disease in Kenya.MethodsWe estimated per-day unit costs of COVID-19 case management for patients. We used a bottom-up approach to estimate full economic costs and adopted a health system perspective and patient episode of care as our time horizon. We obtained data on inputs and their quantities from data provided by three public COVID-19 treatment hospitals in Kenya and augmented this with guidelines. We obtained input prices from a recent costing survey of 20 hospitals in Kenya and from market prices for Kenya.ResultsPer-day, per-patient unit costs for asymptomatic patients and patients with mild-to-moderate COVID-19 disease under home-based care are 1993.01 Kenyan shilling (KES) (US$18.89) and 1995.17 KES (US$18.991), respectively. When these patients are managed in an isolation centre or hospital, the same unit costs for asymptomatic patients and patients with mild-to-moderate disease are 6717.74 KES (US$63.68) and 6719.90 KES (US$63.70), respectively. Per-day unit costs for patients with severe COVID-19 disease managed in general hospital wards and those with critical COVID-19 disease admitted in intensive care units are 13 137.07 KES (US$124.53) and 63 243.11 KES (US$599.51).ConclusionCOVID-19 case management costs are substantial, ranging between two and four times the average claims value reported by Kenya’s public health insurer. Kenya will need to mobilise substantial resources and explore service delivery adaptations that will reduce unit costs.

Essential Emergency and Critical Care: a consensus among global clinical experts

“…The following items are required for a hospital to be ready to provide the care of critically ill patients BMJ Global Health high cost per recovery and risks diverting scarce resources to a few individuals. [55][56][57][58][59][60] Fortunately, the focus has shifted in the global pandemic response from advanced critical care towards securing basic oxygen delivery systems 61 62 underscored by statements from the WHO and other partners. 63 64 The impact of this shift, in and beyond the pandemic, could be even greater if the necessary processes for BMJ Global Health the effective use of oxygen and other care specified in EECC were included in the scale-up.…”

Modelling the cost-effectiveness of essential and advanced critical care for COVID-19 patients in Kenya

“…Details of the costing and results are reported elsewhere. 16 Effectiveness and cost-effectiveness measurement The model's primary outcome measure is the cost per disability adjusted life years (DALYs) averted. DALYs were calculated as the sum of years of life lost (YLL) and years of life with disability (YLD).…”

Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity

“…This is especially since reverse transcription-polymerase chain reaction (RT-PCR) testing from nasopharyngeal swab samples, which is the current gold standard, would require suitably equipped laboratories and trained personnel to conduct the assay. It is also costly, with the reagent cost alone estimated at USD17.22 per test [ 4 ]. These challenges make widespread implementation of RT-PCR challenging.…”